Florida Company Profile
✉ Email this page to a colleague
What is the competitive landscape for FLORIDA
FLORIDA has two approved drugs.
Drugs and US Patents for Florida
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Florida | ABIRATERONE ACETATE | abiraterone acetate | TABLET;ORAL | 215086-001 | Mar 23, 2023 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Florida | OLOPATADINE HYDROCHLORIDE | olopatadine hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 208637-001 | Feb 19, 2020 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.

